Respiratory depression after epidural morphine--an experimental and clinical study

Area of Science:

• Anesthesiology
• Pharmacology
• Respiratory Physiology

Background:

• Epidural morphine is used for post-operative pain management.
• Understanding its effects on respiratory function is crucial for patient safety.

Purpose of the Study:

• To investigate the dose-dependent effects of epidural morphine on ventilatory responses in healthy volunteers.
• To evaluate the impact of epidural morphine on ventilatory function in surgical patients.
• To determine if naloxone can prevent these ventilatory changes.

Main Methods:

• Experimental study with 20 volunteers receiving 2, 4, or 10 mg epidural morphine.
• Clinical study with 10 surgical patients receiving 4 mg epidural morphine.
• Measurement of end-tidal PCO2 (PETCO2) and minute ventilation during CO2 challenge.
• Naloxone infusion administered to assess its preventative effect.

Main Results:

• A dose-related decrease in ventilatory drive was observed with epidural morphine.
• Increased PETCO2 and reduced minute ventilation occurred up to 5 hours post-injection for 2- and 4-mg doses.
• The 10-mg dose caused significant, prolonged reduction in ventilation and elevated PETCO2.
• Surgical patients showed higher and longer-lasting PETCO2 elevation than volunteers with the same dose.

Conclusions:

• Epidural morphine causes dose-dependent respiratory depression.
• Post-surgical patients may experience more pronounced and prolonged ventilatory effects.
• Further research is needed to explore naloxone's efficacy in mitigating these effects.